Biovac, a leading African vaccine manufacturer, has secured a major financing package from the International Finance Corporation (IFC), the EIB Group, and the European Commission to build Africa’s first end-to-end multi-vaccine manufacturing facility. The project will increase access to life-saving vaccines, strengthen the continent’s capacity to prepare for future pandemics, and advance Africa’s long-term health resilience. The project will expand Africa’s vaccine manufacturing capacity, support equitable access to essential immunisations, and strengthen preparedness for future pandemics. The investment is enabled by a financing package led by IFC as the mandated…
Read MoreIFC, EIB Group and European Commission back Biovac to build Africa’s first end-to-end multi-vaccine manufacturing site, advancing vaccine self-reliance
